Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2025年2月26-28日
日本京都, Westin Miyako Kyoto

會前研討會 (上午) & 主會議 第1天 (下午)

Pre-Conference Workshops (am) & Main Conference Day 1 Plenary (pm)

8:00am - 9:00am60分鐘
Registration and Coffee
報到・咖啡時光
    Optional Pre-Conference Workshops
    可選選項：會前研討會
    9:00am - 9:10am10分鐘
    Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
    研討會#1：大規模寡核苷酸生產分析
    Workshop Moderator's Opening Remarks: Workshop #1
    研討會主持人致辭：研討會#1
    • Thomas Rupp - Managing Director, Axolabs Berlin GmbH
    9:00am - 9:10am10分鐘
    Workshop #2: Innovations and Challenges in Peptide Manufacturing
    研討會#2：胜肽製造的創新與挑戰
    Workshop Co-Moderators' Opening Remarks: Workshop #2
    研討會主持人致辭：研討會#2
    • Bruce Morimoto, PhD - Vice President, Drug Development, Alto Neuroscience
    • Robert Hagopian - Director Business Development, PolyPeptide Group
    9:10am - 9:55am45分鐘
    Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
    研討會#1：大規模寡核苷酸生產分析
    Large Scale Manufacturing: Challenges and Solutions
    大規模製造：課題與解決方案
    • Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
    9:10am - 9:50am40分鐘
    Workshop #2: Innovations and Challenges in Peptide Manufacturing
    研討會#2：胜肽製造的創新與挑戰
    Challenges of Raw Material Acquisition for Peptide Synthesis
    採購胜肽合成原料的課題
    • Robert Hagopian - Director Business Development, PolyPeptide Group
    9:50am - 10:35am45分鐘
    Workshop #2: Innovations and Challenges in Peptide Manufacturing
    研討會#2：胜肽製造的創新與挑戰
    Sustainability Challenge in Cyclic Peptide Synthesis: The Power of Crystallization and CSPS
    環肽合成上的可持續性課題：結晶和 CSPS 的力量
    • Hiroshi Iwamura, PhD - Deputy Head of API Process Development Department, Chugai Pharmaceutical Co., Ltd.
    9:55am - 10:40am45分鐘
    Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
    研討會#1：大規模寡核苷酸生產分析
    Designing a Facility: Challenges and Solutions
    設備設計：課題與解決方案
    • Thomas Rupp - Managing Director, Axolabs Berlin GmbH
    10:35am - 11:10am35分鐘
    Workshop #2: Innovations and Challenges in Peptide Manufacturing
    研討會#2：胜肽製造的創新與挑戰
    Networking Refreshment Break
    互動交流休息時間
      10:40am - 11:15am35分鐘
      Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
      研討會#1：大規模寡核苷酸生產分析
      Networking Refreshment Break
      互動交流休息時間
        11:10am - 11:50am40分鐘
        Workshop #2: Innovations and Challenges in Peptide Manufacturing
        研討會#2：胜肽製造的創新與挑戰
        Crystallisation as a Purification and IP-extension) Strategy in Peptide Manufacturing
        作為純化方式的結晶化與胜肽製造上的 IP 擴展策略
        • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
        11:15am - 12:00pm45分鐘
        Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
        研討會#1：大規模寡核苷酸生產分析
        Critical Quality Attributes (CQA): How to Maintain During Upscaling
        CQA (重要品質属性)：擴大規模期間的維持方法
        • Hagen Cramer, PhD - Chief Technology Officer, QurAlis
        11:50am - 12:30pm40分鐘
        Workshop #2: Innovations and Challenges in Peptide Manufacturing
        研討會#2：胜肽製造的創新與挑戰
        Late Breaking Presentation
        發表最新成果
          12:00pm - 12:30pm30分鐘
          Workshop #1: Oligonucleotide Manufacturing Insights At Large Scale
          研討會#1：大規模寡核苷酸生產分析
          Panel Discussion and Q&A with Workshop Speakers
          與研討會演講嘉賓進行小組討論和問與答
          • Thomas Rupp - Managing Director, Axolabs Berlin GmbH
          • Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
          • Hagen Cramer, PhD - Chief Technology Officer, QurAlis
          12:30pm - 1:45pm75分鐘
          Close of Workshop and Luncheon for Morning Workshop Attendees Only
          研討會閉幕、午餐會（僅限上午研討會參與者參加）
            1:45pm - 1:50pm5分鐘
            Main Conference Plenary Keynote Session
            主會議：主題講演單元
            Chairperson’s Remarks: Keynote Day 1
            主席致辭：主題講演（第1天）
            • Yogesh Sanghvi, PhD - President, Rasayan Inc.
            1:50pm - 2:20pm30分鐘
            Main Conference Plenary Keynote Session
            主會議：主題講演單元
            RaPID Display and Selection of Pseudo-natural Products
            RaPID顯示方法及偽天然產物
            • Hiroaki Suga, PhD - Professor of Chemistry, School of Science, University of Tokyo, Japan
            2:20pm - 2:50pm30分鐘
            Main Conference Plenary Keynote Session
            主會議：主題講演單元
            Biological Research with Thiomorpholino Oligonucleotides (TMOs)
            TMO (Thiomorpholino Oligonucleotides) 相關之生物學研究
            • Marvin Caruthers, PhD - Distinguished Professor, Biochemistry, University of Colorado
            2:50pm - 3:20pm30分鐘
            Main Conference Plenary Keynote Session
            主會議：主題講演單元
            RNA Therapeutics Modalities and Targeted Delivery Approaches for Developing Transformational Medicines for Patients
            為患者開發創新藥物所用的 RNA 治療方式和標靶遞送方法
            • Tamar Grossman, PhD - VP, Global Head of RNA, Gene Therapy and Delivery, Johnson & Johnson Innovative Medicine
            3:20pm - 4:00pm40分鐘
            Main Conference Plenary Keynote Session
            主會議：主題講演單元
            Networking Refreshment Break
            互動交流休息時間
              4:00pm - 4:30pm30分鐘
              Main Conference Plenary Keynote Session
              主會議：主題講演單元
              Cell Penetrating Properties of Cyclotides and Their Applications for Intracellular Targets
              環肽的細胞滲透特性及其在細胞內靶標的應用
              • David Craik, PhD - Professor of Biomolecular Structure, University of Queensland
              4:30pm - 5:00pm30分鐘
              Main Conference Plenary Keynote Session
              主會議：主題講演單元
              State of the Art siRNA and Future Perspectives
              尖端siRNA及未來展望
              • Tomaz Einfalt, PhD - Principal Investigator II xRNA, Novartis Institutes for BioMedical Research
              5:00pm - 5:30pm30分鐘
              Main Conference Plenary Keynote Session
              主會議：主題講演單元
              Therapeutic Genome Editing with ePsCas9 Using Lipid Nanoparticles
              利用脂質奈米粒子透過 ePsCas9 進行治療性基因組編輯
              • Grzegorz Sienski, PhD - Director and Project Leader, AstraZeneca
              5:30pm - 5:35pm5分鐘
              Close of Day One
              第1天結束
                Next主會議 第2天

                * 活動內容有可能不事先告知作更動及調整。